Peter Hau

Also affiliated with University of Regensburg

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials”.

Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials

Journal of Neuro-Oncology(2017)10.1007/s11060-016-2362-z

N/A

1.7DataRank · unranked

30 citations

Dorothea Soeldner, Christina Wendl, Dilek Urkan, Joji B. Kuramatsu, Corinna Seliger +5 more

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology(2009)10.1016/s1470-2045(09)70025-7

N/A

1.3DataRank · unranked

7738 citations

Monika E. Hegi, Martin J. van den Bent, Martin JB Taphoorn, Robert C. Janzer, Samuel K. Ludwin +25 more

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

New England Journal of Medicine(2005)10.1056/nejmoa043331

N/A

1.3DataRank · unranked

7181 citations

Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller +15 more

Tenascin-C protein is induced by Transforming Growth Factor-ß1 but does not correlate with time to tumor progression in high-grade gliomas

Journal of Neuro-Oncology(2006)10.1007/s11060-005-9000-5

N/A

0.470DataRank · unranked

22 citations

Leoni A. Kunz-Schughart, Petra Rümmele, Füsun Arslan, Anett Dörfelt, Horst Koch +6 more

Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa097

N/A

0DataRank · unranked

14 citations

Brett Theeler, Brittany Cordeiro, Ira J. Dunkel, Peter Hau, Anita Mahajan +35 more

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Neuro-Oncology(2022)10.1093/neuonc/noac209.274

N/A

0DataRank · unranked

0 citations

Thomas Zeyen, Uwe Schlegel, Lazaros Lazaridis, Jan‐Michael Werner, Julia Onken +38 more